This protocol describes a survey undertaken to acquire a snapshot of the distribution of Clostridioides difficile strains in tertiary acute care hospitals in the European Union/European Economic Area (EU/EEA) in 2022–2023
Version 6.1 is the final protocol for the third EU-wide point prevalence survey in acute care hospitals (PPS 2022–2023). It contains important changes compared to protocol version 5.3 (PPS 2016–2017), including on healthcare-associated COVID-19.
This key provides the non-specialist with reference material to help recognise an invasive mosquito species and gives details on the morphology to help with verification.
This protocol is to ensure standardisation of definitions, data collection and reporting procedures for hospitals participating in the national/regional surveillance of healthcare-associated infections in intensive care units across Europe.
Version 5.3 is the final protocol for the second EU-wide point prevalence survey (PPS 2016–2017). It contains major changes compared to protocol version 4.3 (PPS 2011–2012). Compared to versions 5.1 (January 2016) and 5.2 (May 2016), the current version only contains a few corrections, editorial changes and clarifications.
The aim of this document is to highlight measures that can effectively reduce the risk of importation and local transmission of pathogens transmitted by Ae. aegypti and Ae. albopictus. The main diseases of concern in this context are Zika, dengue, chikungunya and yellow fever.
This ECDC tutorial provides practical information on the proper use of PPE at the point of care, including technical requirements and procurement aspects.
This document outlines current monitoring processes for returning healthcare workers and provides different options for reducing the risk of transmission of Ebola virus disease from infected healthcare workers returning to the EU/EEA.
This document aims to provide guidance to EU/EEA public health authorities for the management of those having had contact with EVD cases. It is an update of the original document from 22 October.